<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
August 9, 2000
------------------
Date of Report
(Date of earliest event reported)
IMMUNEX CORPORATION
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Washington 0-12406 51-0346580
---------------------------- ---------------------- ----------------
(State or Other Jurisdiction (Commission File No.) (IRS Employer
of Incorporation) Identification No.)
51 University Street, Seattle, Washington 98101
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(206) 587-0430
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
None
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events
On August 9, 2000, Immunex Corporation announced that it had filed a Form
S-3 shelf registration statement with the Securities and Exchange Commission for
the sale of up to 70 million shares of Immunex common stock by it and American
Home Products Corporation, its principal shareholder. In addition, Immunex and
American Home Products Corporation announced a number of new business
arrangements and agreements between the two companies, including an amendment to
Immunex's existing governance agreement. A copy of the governance agreement
amendment is attached to this report as Exhibit 10.1. Copies of the press
releases relating to these announcements are attached to this report as Exhibits
99.1 and 99.2.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
10.1 Amendment No. 2 to Amended and Restated Governance Agreement
among Lederle Oncology Corporation, American Cyanamid Company
and Immunex dated as of August 9, 2000
99.1 Immunex Press Release Dated August 9, 2000
99.2 Immunex Corporation and American Home Products
Corporation Joint Press Release Dated August 9, 2000
PAGE 2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMMUNEX CORPORATION
Dated: August 9, 2000 By /s/ David A. Mann
--------------------------------
Name: David A. Mann
Its: Senior Vice President, Chief
Financial Officer and Treasurer
PAGE 3
<PAGE>
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------
10.1 Amendment No. 2 to Amended and Restated Governance Agreement
among Lederle Oncology Corporation, American Cyanamid Company
and Immunex dated as of August 9, 2000
99.1 Immunex Press Release Dated August 9, 2000
99.2 American Home Products Corporation and Immunex Corporation
Joint Press Release Dated August 9, 2000
PAGE 4
